SCPH
scPharmaceuticals Inc.
$5.63
$0.00(0.00%)
90
Overall
--
Value
90
Tech
--
Quality
Market Cap
$300.07M
Volume
676.22K
52W Range
$1.94 - $6.28
Target Price
$11.84
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $39.0K | $56.0K | $51.0K | $51.0K | $47.0K | $13.6M | $36.3M | ||
| Total Revenue | $39.0K | $56.0K | $51.0K | $51.0K | $47.0K | $13.6M | $36.3M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | $3.8M | $11.4M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $39.0K | $56.0K | $51.0K | $51.0K | $47.0K | $9.8M | $25.0M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-29.7M | $32.9M | $29.9M | $25.8M | $36.2M | $69.0M | $101.1M | ||
| Research & Development | $15.9M | $24.6M | $18.1M | $16.0M | $15.5M | $11.8M | $12.1M | ||
| Research Expense | $15.9M | $24.6M | $18.1M | $16.0M | $15.5M | $11.8M | $12.1M | ||
| Selling, General & Administrative | $13.7M | $8.3M | $11.8M | $9.8M | $20.6M | $53.4M | $77.6M | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | $79.0K | $1.1M | ||
| General & Administrative Expenses | $13.7M | $8.3M | $11.8M | $9.8M | $20.6M | $53.4M | $77.6M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | $79.0K | $1.1M | ||
| Salaries & Wages | $-2.1M | $-1.4M | -- | -- | -- | $4.9M | $5.4M | ||
| Depreciation & Amortization | $-38.0K | $-37.0K | $34.0K | $34.0K | $37.0K | $24.0K | $20.0K | ||
| Depreciation & Amortization | $-38.0K | $-37.0K | $34.0K | $34.0K | $37.0K | $24.0K | $20.0K | ||
| Other Operating Expenses | $-483.0K | $-490.0K | $-145.0K | $-203.0K | $-129.0K | $-102.0K | $-147.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-29.7M | $-32.9M | $-29.9M | $-25.8M | $-36.2M | $-55.4M | $-64.8M | ||
| EBITDA | $-27.7M | $-30.9M | $-29.2M | $-24.9M | $-33.1M | $-46.1M | $-77.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $1.4M | $1.8M | $2.6M | $2.6M | $3.3M | $8.1M | $7.6M | ||
| Intinc | $1.7M | $1.7M | $315.0K | $49.0K | $1.2M | $5.1M | $3.4M | ||
| Net Non-Operating Interest Income/Expense | $280.0K | $-107.0K | $-2.3M | $-2.5M | $-2.1M | $-3.0M | $-4.1M | ||
| Other Income/Expense | $56.0K | $-16.0K | $4.0K | $-315.0K | $1.4M | $-3.6M | $9.4M | ||
| Other Special Charges | $-56.0K | $16.0K | $-4.0K | $315.0K | $1.4M | $3.6M | $-9.4M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-28.0M | $-31.2M | $-29.6M | $-25.5M | $-33.5M | $-46.7M | $-77.6M | ||
| Pre-Tax Income | $-29.4M | $-33.0M | $-32.2M | $-28.0M | $-36.8M | $-54.8M | $-85.1M | ||
| NET INCOME | |||||||||
| Net Income | $-29.4M | $-33.0M | $-32.2M | $-28.0M | $-36.8M | $-54.8M | $-85.1M | ||
| Net Income (Continuing Operations) | $-29.4M | $-33.0M | $-32.2M | $-28.0M | $-36.8M | $-54.8M | $-85.1M | ||
| Net Income (Discontinued Operations) | $-29.4M | $-33.0M | $-32.2M | $-28.0M | $-36.8M | $-54.8M | $-85.1M | ||
| Net Income (Common Stockholders) | $-29.4M | $-33.0M | $-32.2M | $-28.0M | $-36.8M | $-54.8M | $-85.1M | ||
| Normalized Income | -- | -- | -- | $-22.1M | -- | -- | $-77.5M | ||
| TOTALS | |||||||||
| Total Expenses | $-29.7M | $32.9M | $29.9M | $25.8M | $36.2M | $72.8M | $112.5M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $18.6M | $18.6M | $24.6M | $27.4M | $28.4M | $38.5M | $44.5M | ||
| Average Shares Outstanding (Diluted) | $18.5M | $18.6M | $24.6M | -- | $28.4M | $38.5M | $44.5M | ||
| Shares Outstanding | $18.6M | $21.0M | $27.4M | $27.4M | $35.8M | $36.1M | $50.3M | ||
| Basic EPS | -- | -- | $-1.31 | $-1.02 | $-1.3 | $-1.42 | $-1.91 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-1.31 | $-1.02 | $-1.3 | $-1.42 | $-1.91 | ||
| Diluted EPS | $-1.59 | $-1.77 | $-1.31 | $-1.02 | $-1.3 | $-1.42 | $-1.91 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.77 | -- | -- | $-1.3 | $-1.42 | $-1.91 | ||
| OTHER METRICS | |||||||||
| Other Gand A | $13.7M | $8.3M | $11.8M | $9.8M | $20.6M | $53.4M | $77.6M | ||
| Rent And Landing Fees | $13.7M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SCPH | $5.63 | 0% | 676.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |